Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

BUY
$201.05 - $221.7 $1.17 Million - $1.29 Million
5,810 New
5,810 $1.17 Million
Q3 2022

Nov 02, 2022

BUY
$204.81 - $262.19 $6,144 - $7,865
30 Added 0.49%
6,110 $1.25 Million
Q1 2022

Apr 28, 2022

SELL
$259.82 - $298.18 $77,946 - $89,454
-300 Reduced 4.7%
6,080 $1.6 Million
Q3 2021

Nov 04, 2021

SELL
$274.82 - $308.34 $32,978 - $37,000
-120 Reduced 1.85%
6,380 $1.8 Million
Q1 2021

Apr 19, 2021

SELL
$204.88 - $255.03 $5,122 - $6,375
-25 Reduced 0.38%
6,500 $1.66 Million
Q3 2020

Nov 03, 2020

SELL
$167.03 - $201.3 $18,373 - $22,143
-110 Reduced 1.66%
6,525 $1.23 Million
Q2 2020

Jul 22, 2020

SELL
$113.31 - $182.44 $77,050 - $124,059
-680 Reduced 9.3%
6,635 $1.1 Million
Q1 2020

Apr 23, 2020

SELL
$104.32 - $195.28 $100,147 - $187,468
-960 Reduced 11.6%
7,315 $925,000
Q4 2019

Jan 22, 2020

SELL
$163.48 - $173.61 $211,379 - $224,477
-1,293 Reduced 13.51%
8,275 $1.4 Million
Q3 2019

Nov 12, 2019

BUY
$159.77 - $178.1 $2,875 - $3,205
18 Added 0.19%
9,568 $1.61 Million
Q2 2019

Jul 30, 2019

SELL
$144.16 - $172.9 $50,456 - $60,515
-350 Reduced 3.54%
9,550 $1.65 Million
Q1 2019

Apr 26, 2019

SELL
$123.7 - $156.3 $49,480 - $62,520
-400 Reduced 3.88%
9,900 $1.52 Million
Q4 2018

Feb 15, 2019

SELL
$120.82 - $174.09 $60,410 - $87,045
-500 Reduced 4.63%
10,300 $1.3 Million
Q3 2018

Nov 02, 2018

SELL
$167.67 - $188.27 $12,575 - $14,120
-75 Reduced 0.69%
10,800 $1.88 Million
Q2 2018

Aug 03, 2018

SELL
$160.33 - $189.41 $57,718 - $68,187
-360 Reduced 3.2%
10,875 $1.95 Million
Q3 2017

Nov 20, 2017

BUY
$149.47 - $160.56 $1.68 Million - $1.8 Million
11,235
11,235 $1.7 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Barnett & Company, Inc. Portfolio

Follow Barnett & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barnett & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Barnett & Company, Inc. with notifications on news.